What Records and Slides Are Needed for an MDS Second Opinion?

To get a comprehensive second opinion for Myelodysplastic Syndrome (MDS), the reviewing center will likely request both your clinical medical records and your actual pathology materials. While requirements vary by institution, they often ask for your complete blood count (CBC) trends, transfusion history, original pathology reports, bone marrow aspirate and biopsy slides, flow cytometry results, and genetic reports (cytogenetics, FISH, and Next-Generation Sequencing).

Important first step: Do not attempt to gather or mail physical glass slides or tissue blocks yourself. Always contact the second opinion center first to get their specific checklist. Your local pathology department will coordinate the secure packaging and shipping of biological materials.

Pathology Review vs. Full Clinical Consultation

When seeking a second opinion, it is helpful to understand what type of review you are getting:

• Pathology-Only Review: An expert hematopathologist (a doctor specializing in diagnosing blood cancers) re-evaluates your bone marrow slides, blood smears, and genetic reports to confirm or refine your exact diagnosis ^[1].
• Full Clinical Second Opinion: An MDS-specialized hematologist or oncologist reviews the pathology findings and evaluates your physical health, symptoms, transfusion needs, and treatment goals. They use all this information to calculate your prognostic risk score (using tools like the IPSS-M or IPSS-R) and discuss personalized treatment or transplant options ^[2].

Why an Expert Pathology Review Matters in MDS

MDS can be complex to diagnose because no single test can completely prove or exclude it. Diagnosis requires integrating persistent low blood counts, visual cell changes (morphology), blast cell counts, and genetic findings, while carefully ruling out other causes ^[3]. An expert review can provide clarity in several ways:

• Distinguishing MDS Mimics: Many non-cancerous conditions cause low counts and cell changes that look like MDS. These include vitamin deficiencies, autoimmune issues, toxic exposures, and age-related mutations known as clonal hematopoiesis ^[4]. Finding a genetic mutation does not automatically mean you have MDS; expert review helps distinguish MDS from harmless age-related changes.
• Confirming the Exact Diagnosis: Expert review can confirm if you truly have MDS or if your condition better fits a different blood disorder, such as acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML) ^[1]. This is especially valuable if your original marrow sample was diluted with blood (hemodiluted) or had very few cells (hypocellular) ^[5].
• Navigating New Classifications: Medical experts recently split MDS classifications into two different systems (the WHO 5th edition and the ICC). An expert can explain which system they are using and how updated criteria might change your disease label or subtype ^[6].

What Your Second Opinion Center May Request

When you arrange your second opinion, the receiving center will provide a checklist. You will sign a medical release authorization, and your local records or pathology department will send some or all of the following materials:

• Clinical History: This includes your long-term CBC trends, exact history of blood transfusions, prior treatments, and results from previous testing for nutritional or inflammatory issues ^[7].
• Original Pathology Reports: The written baseline interpretation of your marrow, including cellularity and blast percentages ^[8].
• Bone Marrow Aspirate and Biopsy Slides: Physical glass slides (both stained and unstained) allow the expert to personally look at the shape of your cells and check for scarring in the marrow cavity (fibrosis) ^[8].
• Tissue Blocks: The original laboratory may be asked to send the preserved tissue block (paraffin block) from your biopsy so the second institution can run specialized stains or molecular tests ^[9].
• Flow Cytometry: This test detects specific surface and intracellular markers on your cells. It is a helpful adjunct test, though it cannot confirm or exclude MDS on its own and may be less reliable if your marrow sample was hemodiluted ^[10].
• Genetic and Molecular Reports: Cytogenetics (karyotyping) provides a global view of your chromosomes, while FISH targets specific chromosomal abnormalities ^[11]. Next-Generation Sequencing (NGS) reports detail specific gene mutations.

Understanding Your NGS Report and VAF

When reviewing your Next-Generation Sequencing (NGS) report, experts look at specific mutations (like SF3B1 or TP53). While a mutation alone does not dictate your entire treatment plan, it may inform it. For example, certain mutations might make you a candidate for specific therapies (like luspatercept for anemia in certain contexts) or influence discussions about the timing of a stem cell transplant ^{[2] [12]}.

Your NGS report may also include a Variant Allele Frequency (VAF) ^[13]. VAF is the proportion of sequencing reads that contain a specific genetic variant. While it gives doctors an indirect estimate of how many cells carry the mutation, it is not a direct “percentage of mutated cells.” Technical factors, copy-number changes, and whether the mutation was inherited can all make the VAF differ from the actual percentage of affected cells.

Step-by-Step Logistics for Transferring Specimens

1. Do not delay care: Arrange your second opinion in parallel with your recommended care. Never delay urgent treatments for infections, bleeding, or severe anemia while waiting on materials.
2. Contact the receiving center: Ask their second opinion or pathology office for their exact checklist. Clarify if you are getting a pathology-only review or a full clinical consultation. Ask about insurance coverage, referral authorizations, and turnaround time.
3. Sign authorizations: Provide your local hospital with the signed release forms and the receiving center’s shipping instructions.
4. Let the institutions handle the logistics: Your local pathology department will coordinate the secure packaging and use approved, tracked courier services ^[14]. Electronic data should be shared through secure, access-controlled systems ^[15].
5. Ask about returns: Institutions often use internal paperwork (like retention policies or Material Transfer Agreements) to dictate whether your physical slides and blocks will be returned to your local hospital or securely destroyed after the review ^[16]. Ask the receiving center about their policy so you know where your biopsy materials will end up.